| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |